By reflecting underlying inflammatory and fibrotic pathways common to myocardial injury, renal fibrosis, endothelial dysfunction, and metabolic disturbances, galectin-3 integrates these pathologies into a unified concept of multisystem organ dysfunction. Here, LGALS3 is linked to renal fibrosis.